Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Innoviva (INVA) Return on Sales (2016 - 2026)

Innoviva filings provide 15 years of Return on Sales readings, the most recent being 0.01% for Q3 2025.

  • On a quarterly basis, Return on Sales rose 1.0% to 0.01% in Q3 2025 year-over-year; TTM through Sep 2025 was 0.0%, a 0.0% change, with the full-year FY2025 number at 0.01%, up 1.0% from a year prior.
  • Return on Sales hit 0.01% in Q3 2025 for Innoviva, up from 0.01% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 1.76% in Q3 2022 to a low of 0.95% in Q1 2025.
  • Median Return on Sales over the past 5 years was 0.01% (2021), compared with a mean of 0.2%.
  • Biggest five-year swings in Return on Sales: plummeted -275bps in 2021 and later surged 175bps in 2022.
  • Innoviva's Return on Sales stood at 0.06% in 2021, then crashed by -61bps to 0.1% in 2022, then soared by 56bps to 0.04% in 2023, then plummeted by -98bps to 0.09% in 2024, then soared by 110bps to 0.01% in 2025.
  • The last three reported values for Return on Sales were 0.01% (Q3 2025), 0.01% (Q2 2025), and 0.95% (Q1 2025) per Business Quant data.